Skip to content

Effects of repetitive transcranial magnetic stimulation on motor function of upper limb and neurological plasticity in stroke patients with hemiplegia

Effects of repetitive transcranial magnetic stimulation on motor function of upper limb and neurological plasticity in stroke patients with hemiplegia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018984
Enrollment
Unknown
Registered
2018-10-20
Start date
2018-10-12
Completion date
Unknown
Last updated
2020-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

Group 2:Routine treatment + High-frequency rTMS

Sponsors

Nanjing First Hospital Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. First onset, duration of 24 hours to 6 weeks, the general situation is stable, confirmed by magnetic resonance DWI acute onset, and for subcortical ischemic stroke patients; 2. Hemiplegic patients with upper extremity hand dysfunction were classified as hemiplegic patients according to the functional classification of hemiplegic hand (hemiplegic hand function assessment included five practical hand functions for daily life, and patients with complete hemiplegia who could complete at least one of these five functions were hemiplegic patients with complete hand function. Part of hemiplegia patients, and the duration is longer than 48 hours; 3. The patients in the study group were clear-minded, without obvious speech cognitive impairment (MMSE < 22), and could cooperate with MRI examination; 4. there were no long-term alcoholism and long-term use of CNS drugs; 5. of the patients were 30-65 years old and volunteered for the trial.

Exclusion criteria

Exclusion criteria: 1. with severe heart disease or severe physical illness; 2. intracranial metal implanted implants, magnetic materials, pacemakers or skull defects; 3. intracranial hypertension; 4. persons or family history of epilepsy or mental illness; 5. the history of drugs used to alter cortical excitability (sedation and antidepressants): 6. pregnant women; 7. researchers believe that those who do not conform to the inclusion criteria.

Design outcomes

Primary

MeasureTime frame
Upper Extremity Fugl-Meyer Assessment;Wolf Motor Function Test ,;FTHUE-HK;VBM;rs-fMRI;Diffusion Tensor imaging;

Contacts

Public ContactTing Yang

Nanjing First Hospital Nanjing Medical University

yangting821102@163.com+86 13952021782

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026